Projected settlement ranges For severe gastroparesis cases requiring hospitalization, feeding tubes, or surgery, projections range from 350,000 to over 500,000 dollars
A Phase 2 trial (a mid-stage human trial, typically involving a few hundred participants) published in the New England Journal of Medicine in 2023 reported an average weight loss of about 24% at 48 weeks with the highest dose
These studies underscore the essential role of GSH in normal functioning of the liver
Loss of muscle mass, especially with rapid weight reduction during GLP-1RA therapy, has prompted studies into the utility of agents that promote muscle growth
Yang, T., Lin, W., Chuang, Y., Wang, C., Huang, H., & Chan, H